Lymphoma, T-Cell, Cutaneous

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

Active, not recruiting
  • Mycosis Fungoides
  • +2 more
  • Graz, Austria
  • +53 more
Dec 12, 2022

Relapsed or Refractory CD30+ Malignancies When Re-treated With

Completed
  • Hodgkin Disease
  • Lymphoma, T-Cell, Cutaneous
  • No Intervention
  • San Bartolome, Alicante, Spain
  • +29 more
Jul 28, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

No longer available
  • Disease, Hodgkin
  • +3 more
  • brentuximab vedotin
  • Stanford, California
  • +30 more
Sep 17, 2020